![](/img/cover-not-exists.png)
A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma
Berenson, James, Manges, Robert, Badarinath, Suprith, Cartmell, Alan, McIntyre, Kristi, Lyons, Roger, Harb, Wael, Mohamed, Hesham, Nourbakhsh, Ali, Rifkin, RobertVolume:
92
Language:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.24687
Date:
May, 2017
File:
PDF, 753 KB
english, 2017